Liquid-based cytology - LBC + Chlamydia tr. + Ureaplasma sp. + Mycoplasma g. with sample collection at a medical centre
Liquid-based cytology is a modern preventive screening for cervical cancer, designed to detect neoplastic lesions caused by the HPV virus. The test additionally looks for infection with Chlamydia, Ureaplasma and Mycoplasma microorganisms.
- Product description
- Step-by-step purchase
- Important information
- Documents
Liquid-based cytology + Chlamydia tr. + Ureaplasma sp. + Mycoplasma g.
Quick diagnosis of neoplastic lesions in the early stage allows for effective treatment. The test additionally looks for infection with Chlamydia, Ureaplasma and Mycoplasma microorganisms. If cervical cancer is detected early, it is almost 100% curable. For this reason, regular screening (at least every 3 years) is so important.
Liquid-based cytology (LBC) is an alternative to conventional cytology. It is a modern and, above all, precise method of screening.
Why you should get tested:
- Thanks to the modern technique of processing the collected material, it is possible to obtain a greater number of cells to be assessed, and thus the test results are more accurate.
- The rate of detection of cancerous and pre-cancerous lesions when using liquid-based cytology is significantly higher than in the case of conventional cytology, therefore the screening is more sensitive.
- Liquid-based cytology is more accurate - it allows for a greater detectability of lesions compared to conventional cytology.
- More accurate results mean better and faster diagnostic decisions.